Insider Transactions Reported by 18 Insiders of Syndax Pharmaceuticals Inc

Symbol
SNDX on Nasdaq
Location
New York, NY

Insiders trading volume in the past year

Syndax Pharmaceuticals Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Michael A. Metzger Chief Executive Officer, Director $19,328,457 -$3,165,629 -14% 09 Feb 2026
Steve M. Sabus Chief Commercial Officer $5,685,614 05 Dec 2022
Keith A. Goldan Chief Financial Officer $5,363,681 -$126,670 -2.3% 09 Feb 2026
Dennis Podlesak Director $5,037,420 -$875,100 -15% 04 Feb 2026
Nicholas A.J. Botwood Head of R&D, CMO $4,955,637 +$105,826 +2.2% 04 Feb 2026
Neil Gallagher President, Head of R&D $2,938,138 10 Feb 2025
Catherine Madigan Chief Medical Officer $2,842,807 02 Feb 2023
Keith Katkin Director $2,605,240 +$91,120 +3.6% 04 Feb 2026
Pierre Legault Director $2,395,140 04 Feb 2026
Jennifer Jarrett Director $2,395,140 04 Feb 2026
Martin H. Huber Jr. Director $2,164,030 +$44,950 +2.1% 04 Feb 2026
William Meury Director $1,802,682 05 Feb 2025
Aleksandra Rizo Director $1,029,490 04 Feb 2026
Michael L. Meyers SVP, Chief Medical Officer $873,600 02 Feb 2022
Briggs Morrison Director $636,283 07 Feb 2024
Fabrice Egros Director $584,483 02 Feb 2022
Alexander Nolte Chief Accounting Officer $439,343 02 Feb 2023
Peter Ordentlich Chief Scientific Officer 15 Feb 2023

Recent Insider Transactions by Companies or Individuals for Syndax Pharmaceuticals Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Michael A. Metzger SNDX Common Stock Sale -3.37% $360,819 $21.03 -17,159 491,690 09 Feb 2026 Direct
Keith A. Goldan SNDX Common Stock Sale -2.37% $71,705 $21.03 -3,410 140,429 09 Feb 2026 Direct
Michael A. Metzger SNDX Common Stock Sale -1.44% $152,835 $20.62 -7,412 508,849 06 Feb 2026 Direct
Keith A. Goldan SNDX Common Stock Sale -1.43% $42,931 $20.62 -2,082 143,839 06 Feb 2026 Direct
Michael A. Metzger SNDX Common Stock Award 72.9% 217,600 516,261 04 Feb 2026 Direct
Michael A. Metzger SNDX Stock Options (Right to buy) Award 440,000 440,000 04 Feb 2026 Direct
Keith A. Goldan SNDX Common Stock Award 55.8% 52,250 145,921 04 Feb 2026 Direct
Keith A. Goldan SNDX Stock Options (Right to buy) Award 118,000 118,000 04 Feb 2026 Direct
Jennifer Jarrett SNDX Common Stock Award 26.7% 24,000 114,000 04 Feb 2026 Direct
Martin H. Huber Jr. SNDX Common Stock Award 30.4% 24,000 103,000 04 Feb 2026 Direct
Nicholas A.J. Botwood SNDX Common Stock Award 170.6% 60,000 95,165 04 Feb 2026 Direct
Nicholas A.J. Botwood SNDX Stock Options (Right to buy) Award 144,700 144,700 04 Feb 2026 Direct
Dennis Podlesak SNDX Common Stock Award 25% 48,000 239,763 04 Feb 2026 Direct
Aleksandra Rizo SNDX Common Stock Award 96% 24,000 49,000 04 Feb 2026 Direct
Keith Katkin SNDX Common Stock Award 24% 24,000 124,000 04 Feb 2026 Direct
Pierre Legault SNDX Common Stock Award 26.7% 24,000 114,000 04 Feb 2026 Direct
Keith A. Goldan SNDX Common Stock Other 1.32% 1,219 93,671 30 Jan 2026 Direct
Keith A. Goldan SNDX Common Stock Gift -1.31% -1,224 92,452 01 Dec 2025 Direct
Michael A. Metzger SNDX Common Stock Sale -34.5% $2,582,021 $16.41 -157,307 298,661 08 Sep 2025 Direct
Michael A. Metzger SNDX Common Stock Options Exercise 52.7% 157,307 455,968 08 Sep 2025 Direct
Michael A. Metzger SNDX Stock options (Right to buy) Options Exercise 157,307 0 08 Sep 2025 Direct
Dennis Podlesak SNDX Common Stock Sale -9.1% $304,170 $15.84 -19,200 191,763 18 Aug 2025 Direct
Dennis Podlesak SNDX Common Stock Options Exercise 10% 19,200 210,963 18 Aug 2025 Direct
Dennis Podlesak SNDX Stock Options (Right to buy) Options Exercise -100% -19,200 0 18 Aug 2025 Direct
Dennis Podlesak SNDX Common Stock Sale -9.1% $298,408 $15.54 -19,200 191,763 15 Aug 2025 Direct
Dennis Podlesak SNDX Common Stock Options Exercise 10% 19,200 210,963 15 Aug 2025 Direct
Dennis Podlesak SNDX Stock Options (Right to buy) Options Exercise -100% -19,200 0 15 Aug 2025 Direct
Dennis Podlesak SNDX Common Stock Sale -9.1% $272,521 $14.19 -19,200 191,763 14 Aug 2025 Direct
Dennis Podlesak SNDX Common Stock Options Exercise 10% 19,200 210,963 14 Aug 2025 Direct
Dennis Podlesak SNDX Stock Options (Right to buy) Options Exercise -100% -19,200 0 14 Aug 2025 Direct
Keith A. Goldan SNDX Common Stock Other 1.33% 1,226 93,676 31 Jul 2025 Direct
Keith A. Goldan SNDX Common Stock Sale -1.38% $12,033 $9.28 -1,296 92,450 16 Jul 2025 Direct
Michael A. Metzger SNDX Common Stock Sale -2.46% $69,953 $9.28 -7,534 298,661 16 Jul 2025 Direct
Keith A. Goldan SNDX Common Stock Purchase 3.31% 3,000 93,746 19 May 2025 Direct
Martin H. Huber Jr. SNDX Common Stock Purchase 6.76% $44,950 $8.99 5,000 79,000 19 May 2025 Direct
Keith Katkin SNDX Common Stock Purchase 11.1% $91,120 $9.11 10,000 100,000 19 May 2025 Direct
Nicholas A.J. Botwood SNDX Common Stock Purchase 50.3% $105,826 $9.00 11,765 35,165 16 May 2025 Direct
Michael A. Metzger SNDX Common Stock Options Exercise 2.02% 6,074 306,195 14 Mar 2025 Direct
Michael A. Metzger SNDX Stock options (Right to buy) Options Exercise 6,074 0 14 Mar 2025 Direct
Michael A. Metzger SNDX Common Stock Sale -2.54% $117,564 $15.05 -7,814 300,121 04 Mar 2025 Direct
Michael A. Metzger SNDX Common Stock Options Exercise 2.6% 7,814 307,935 04 Mar 2025 Direct
Michael A. Metzger SNDX Stock options (Right to buy) Options Exercise 7,814 0 04 Mar 2025 Direct
Keith A. Goldan SNDX Common Stock Sale -4% $58,559 $15.50 -3,777 90,746 10 Feb 2025 Direct
Michael A. Metzger SNDX Common Stock Sale -4.24% $206,017 $15.50 -13,288 300,121 10 Feb 2025 Direct
Neil Gallagher SNDX Common Stock Sale -5.15% $71,597 $15.50 -4,618 85,095 10 Feb 2025 Direct
Neil Gallagher SNDX Common Stock Award 87.6% 41,900 89,713 05 Feb 2025 Direct
Neil Gallagher SNDX Stock Options (Right to buy) Award 110,500 110,500 05 Feb 2025 Direct
Keith A. Goldan SNDX Common Stock Award 79.6% 41,900 94,523 05 Feb 2025 Direct
Keith A. Goldan SNDX Stock Options (Right to buy) Award 110,500 110,500 05 Feb 2025 Direct
Michael A. Metzger SNDX Common Stock Award 91.2% 149,500 313,409 05 Feb 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.